UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) | November 12, 2008 |
AVOCENT CORPORATION |
(Exact name of registrant as specified in its charter) |
DELAWARE | 000-30575 | 91-2032368 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
4991 CORPORATE DRIVE | HUNTSVILLE, AL 35805 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code | (256) 430-4000 |
n/a |
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On November 12, 2008, Avocent Corporation publicly disseminated a press release reaffirming guidance for the fourth quarter of 2008 as set forth in its press release dated October 21, 2008. The Company expects to provide more detail at a presentation on November 12th in New York and in a live simulcast of the meeting on the Internet. The information contained in that press release is incorporated herein by reference and furnished as Exhibit 99.22 hereto.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. | |
Exhibit Number | Description of Exhibit | |
99.22 | Press Release issued November 12, 2008 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AVOCENT CORPORATION | ||
Date: | November 12, 2008 | ||
|
| By: | /s/ Edward H. Blankenship |
Edward H. Blankenship | |||
Senior VP of Finance and Chief Financial Officer |
EXHIBIT INDEX
Exhibit Number | Description of Exhibit | |
99.22 | Press Release issued November 12, 2008 |